Neuroimaging predictors of treatment response in anxiety disorders
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Although several psychological and pharmacological treatment options are available for anxiety disorders, not all patients respond well to each option. Furthermore, given the relatively long duration of adequate treatment trials, finding a good treatment fit can take many months or longer. Thus, both clinicians and patients would benefit from the identification of objective pre-treatment measures that predict which patients will best respond to a given treatment. Recent studies have begun to use biological measures to help predict symptomatic change after treatment in anxiety disorders. In this review, we summarize studies that have used structural and functional neuroimaging measures to predict treatment response in obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and social anxiety disorder (SAD). We note the limitations of the current studies and offer suggestions for future research. Although the literature is currently small, we conclude that pre-treatment neuroimaging measures do appear to predict treatment response in anxiety disorders, and future research will be needed to determine the relative predictive power of neuroimaging measures as compared to clinical and demographic measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083 · cited 2×
“The direction of functional abnormalities in the mPFC in this disorder is less clear, with some studies reporting increased activation and others reporting decreased activation [51].”
BackgroundSelf-citationHoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 1×
“Although cognitive-behavioral therapies are moderately effective in the treatment of anxiety disorders, there appears to be room for improvement [7-9], perhaps especially in the case of panic disorder and generalized anxiety disorder (GAD) [8].”
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.004 · Cited by 1,397 · cited 1×
“Some neurocircuitry models [46,47] posit that the amygdala is hyperresponsive in PTSD, perhaps accounting for hypervigilance, increased arousal, and the persistence of trauma-related memories.”
BackgroundSelf-citationBaxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
Milad, M. R., Wright, C. I., Orr, S. P., Pitman, R. K., Quirk, G. J., & Rauch, S. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.011 · Cited by 1,197
Rauch, S. L., Whalen, P. J., Shin, L. M., McInerney, S. C., Macklin, M. L., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00828-3 · Cited by 1,111
Self-citationCingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
Shin, L. M., Wright, C. I., Cannistraro, P. A., Wedig, M. M., McMullin, K., Martis, B., Macklin, M. L., Lasko, N. B., Cavanagh, S. R., Krangel, T. S., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.273 · Cited by 960
Self-citationA meta-analysis of structural brain abnormalities in PTSD
KARL, A., SCHAEFER, M., MALTA, L., DORFEL, D., ROHLEDER, N., & WERNER, A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.03.004 · Cited by 881
Rauch, S. L. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010062008 · Cited by 880 · cited 1×
“, [25-28], although the direction of the abnormalities is not entirely uniform across studies).”
BackgroundToward a neurobiology of obsessive-compulsive disorder
Graybiel, A. M., & Rauch, S. L. (2000) · Neuron · doi:10.1016/s0896-6273(00)00113-6 · Cited by 864 · cited 2×
“, [23]), caudate activity predicted treatment response only in”
BackgroundShin, L. M., Orr, S. P., Carson, M. A., Rauch, S. L., Macklin, M. L., Lasko, N. B., Peters, P. M., Metzger, L. J., Dougherty, D. D., Cannistraro, P. A., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.2.168 · Cited by 790
Self-citationMataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716
Monk, C. S., Telzer, E. H., Mogg, K., Bradley, B. P., Mai, X., Louro, H. M. C., Chen, G., McClure-Tone, E. B., Ernst, M., & Pine, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.568 · Cited by 682 · cited 2×
“Although relatively few functional neuroimaging studies of GAD exist in the literature, there has been some support for increased activation in the amygdala and mPFC in GAD relative to comparison groups ([70-73], but see also [74,75]).”
BackgroundIs cognitive–behavioral therapy more effective than other therapies?
Tolin, D. F. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.05.003 · Cited by 645
Patel, R., Spreng, R. N., Shin, L. M., & Girard, T. A. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.003 · Cited by 546 · cited 1×
“Neuroimaging studies of PTSD have generally reported increased activation in the amygdala, insular cortex, and dorsal anterior cingulate cortex (dACC), and decreased activation in the mPFC [48-51].”
Self-citationPhan, K. L., Fitzgerald, D. A., Nathan, P. J., & Tancer, M. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.012 · Cited by 539 · cited 1×
“[77-79]), which is positively correlated with symptom severity (e.”
Furmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Långström, B., & Fredrikson, M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.425 · Cited by 530 · cited 1×
“, [80,81]) and appears to decrease after successful treatment [82,83].”
BackgroundA meta-analysis of functional neuroimaging in obsessive-compulsive disorder
Whiteside, S. P., Port, J. D., & Abramowitz, J. S. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2004.07.001 · Cited by 520
Quantitative meta-analysis of neural activity in posttraumatic stress disorder
Hayes, J. P., Hayes, S. M., & Mikedis, A. M. (2012) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-2-9 · Cited by 452 · cited 1×
“Neuroimaging studies of PTSD have generally reported increased activation in the amygdala, insular cortex, and dorsal anterior cingulate cortex (dACC), and decreased activation in the mPFC [48-51].”
BackgroundAbnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder
McClure, E. B., Monk, C. S., Nelson, E. E., Parrish, J. M., Adler, A., Blair, R. J. R., Fromm, S., Charney, D. S., Leibenluft, E., Ernst, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.97 · Cited by 431 · cited 1×
“Although relatively few functional neuroimaging studies of GAD exist in the literature, there has been some support for increased activation in the amygdala and mPFC in GAD relative to comparison groups ([70-73], but see also [74,75]).”
BackgroundThickness of ventromedial prefrontal cortex in humans is correlated with extinction memory
Milad, M. R., Quinn, B. T., Pitman, R. K., Orr, S. P., Fischl, B., & Rauch, S. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502441102 · Cited by 412 · cited 1×
“Given that CBT involves extinction-like processes and that ventral medial prefrontal cortex (mPFC) is critical for the retention of extinction memory [42,43], it makes sense that patients with greater pretreatment gray matter volume in ventral mPFC would show greater symptomatic improvement with CBT.”
BackgroundFu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.008 · Cited by 399 · cited 1×
“[88,89], but only one research group has actually examined these different diagnostic groups (OCD, depression,”
BackgroundSaxena, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00082-2 · Cited by 379 · cited 2×
“Saxena and colleagues [33] reported similar findings in a PET study of”
ResultNitschke, J. B., Sarinopoulos, I., Oathes, D. J., Johnstone, T., Whalen, P. J., Davidson, R. J., & Kalin, N. H. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101682 · Cited by 375 · cited 3×
“Although relatively few functional neuroimaging studies of GAD exist in the literature, there has been some support for increased activation in the amygdala and mPFC in GAD relative to comparison groups ([70-73], but see also [74,75]).”
BackgroundGuyer, A. E., Lau, J. Y. F., McClure-Tone, E. B., Parrish, J., Shiffrin, N. D., Reynolds, R. C., Chen, G., Blair, R. J. R., Leibenluft, E., Fox, N. A., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.11.1303 · Cited by 371 · cited 1×
“, [80,81]) and appears to decrease after successful treatment [82,83].”
BackgroundBryant, R. A., Felmingham, K., Kemp, A., Das, P., Hughes, G., Peduto, A., & Williams, L. (2008) · Psychological Medicine · doi:10.1017/s0033291707002231 · Cited by 307
Amygdala Volume Changes in Posttraumatic Stress Disorder in a Large Case-Controlled Veterans Group
Morey, R. A., Gold, A. L., LaBar, K. S., Beall, S. K., Brown, V. M., Haswell, C. C., Nasser, J. D., Wagner, H. R., McCarthy, G., & Mid-Atlantic MIRECC Workgroup, F. T. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.50 · Cited by 289 · cited 1×
“, [52-55]).”
Brody, A. L., Saxena, S., Schwartz, J. M., Stoessel, P. W., Maidment, K., Phelps, M. E., & Baxter, L. R. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00041-9 · Cited by 285 · cited 4×
“[40] studied pre-treatment rCMRglu in patient groups who chose to receive either BT or fluoxetine.”
BackgroundMethodResultInfluentialBlair, K., Shaywitz, J., Smith, B. W., Rhodes, R., Geraci, M., Jones, M., McCaffrey, D., Vythilingam, M., Finger, E., Mondillo, K., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071060 · Cited by 282
Corticolimbic blood flow in posttraumatic stress disorder during script-driven imagery
Britton, J. C., Phan, K. L., Taylor, S. F., Fig, L. M., & Liberzon, I. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.025 · Cited by 265 · cited 1×
“, [58-61]).”
Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging.
Doehrmann, O., Ghosh, S. S., Polli, F. E., Reynolds, G. O., Horn, F., Keshavan, A., Triantafyllou, C., Saygin, Z. M., Whitfield-Gabrieli, S., Hofmann, S. G., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.5 · Cited by 262
Decreased anterior cingulate volume in combat-related PTSD
Woodward, S. H., Kaloupek, D. G., Streeter, C. C., Martinez, C., Schaer, M., & Eliez, S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.033 · Cited by 259
Rotge, J.-Y., Guehl, D., Dilharreguy, B., Cuny, E., Tignol, J., Bioulac, B., Allard, M., Burbaud, P., & Aouizerate, B. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0838 · Cited by 254
Amir, N., Klumpp, H., Elias, J., Bedwell, J. S., Yanasak, N., & Miller, L. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.044 · Cited by 229 · cited 1×
“, [84-86]).”
Predictors of Response to Cognitive-Behavioral Group Therapy for Social Phobia
Chambless, D. L., Tran, G. Q., & Glass, C. R. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00008-x · Cited by 228
Keane, T. M., Kolb, L. C., Kaloupek, D. G., Orr, S. P., Blanchard, E. B., Thomas, R. G., Hsieh, F. Y., & Lavori, P. W. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.6.914 · Cited by 221 · cited 1×
“This approach has been used in other areas of clinical research [90,91], but not yet in the current one.”
MethodEvidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)
Ipser, J. C., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001209 · Cited by 216 · cited 1×
“The percentage of individuals responding to pharmacotherapy appears to be even lower in posttraumatic stress disorder (PTSD) [6].”
BackgroundA functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder
Evans, K. C., Wright, C. I., Wedig, M. M., Gold, A. L., Pollack, M. H., & Rauch, S. L. (2008) · Depression and Anxiety · doi:10.1002/da.20347 · Cited by 211
Saxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., & Baxter, L. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.522 · Cited by 210
Otto, M. W., Pollack, M. H., Gould, R. A., Worthington, J. J., McArdle, E. T., Rosenbaum, J. F., & Heimberg, R. G. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(00)00027-x · Cited by 175 · cited 14×
“In this review, we summarize studies that have used structural and functional neuroimaging measures to predict treatment response in obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and social anxiety disorder (SAD).”
BackgroundInfluentialfMRI predictors of treatment outcome in pediatric anxiety disorders
McClure, E. B., Adler, A., Monk, C. S., Cameron, J., Smith, S., Nelson, E. E., Leibenluft, E., Ernst, M., & Pine, D. S. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0542-9 · Cited by 165 · cited 1×
“[75], McClure and colleagues [76] examined amygdala activa-”
A meta-analysis of cognitive therapy for worry in generalized anxiety disorder
Hanrahan, F., Field, A. P., Jones, F. W., & Davey, G. C. L. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.10.008 · Cited by 159 · cited 1×
“Although cognitive-behavioral therapies are moderately effective in the treatment of anxiety disorders, there appears to be room for improvement [7-9], perhaps especially in the case of panic disorder and generalized anxiety disorder (GAD) [8].”
BackgroundRauch, S. L., Dougherty, D. D., Cosgrove, G. R., Cassem, E. H., Alpert, N. M., Price, B. H., Nierenberg, A. A., Mayberg, H. S., Baer, L., Jenike, M. A., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01188-x · Cited by 150
Krain, A. L., Gotimer, K., Hefton, S., Ernst, M., Castellanos, F. X., Pine, D. S., & Milham, M. P. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.011 · Cited by 147 · cited 1×
“Although relatively few functional neuroimaging studies of GAD exist in the literature, there has been some support for increased activation in the amygdala and mPFC in GAD relative to comparison groups ([70-73], but see also [74,75]).”
Mancebo, M. C., Eisen, J. L., Pinto, A., Greenberg, B. D., Dyck, I. R., & Rasmussen, S. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1107 · Cited by 109 · cited 1×
“For example, a recent naturalistic study of obsessive-compulsive disorder (OCD) revealed that only approximately two-thirds of individuals taking serotonin reuptake inhibitors (SRIs) considered their symptoms very much or much improved [5].”
BackgroundPredictors of treatment response to fluvoxamine in obsessive–compulsive disorder: An fMRI study
Sanematsu, H., Nakao, T., Yoshiura, T., Nabeyama, M., Togao, O., Tomita, M., Masuda, Y., Nakatani, E., Nakagawa, A., & Kanba, S. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.007 · Cited by 68
Evans, K. C., Simon, N. M., Dougherty, D. D., Hoge, E. A., Worthington, J. J., Chow, C., Kaufman, R. E., Gold, A. L., Fischman, A. J., Pollack, M. H., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.69 · Cited by 68 · cited 2×
“In a PET-FDG study, Evans and colleagues [87] found no significant voxelwise correlations between pretreatment rCMRglu in their regions of interest (which included mPFC/ACC, amygdala, hippocampus, parahippocampal gyrus, insula) and symptomatic improvement after treatment with tiagabine.”
Background
Cited by
Anxiety and attention to threat: cognitive mechanisms and treatment with attention bias modification
Mogg, K., & Bradley, B. P. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.08.001 · Cited by 313
Neural circuits in anxiety and stress disorders: a focused review
Liberzon, I., Duval, E., & Javanbakht, A. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s48528 · Cited by 253
Månsson, K. N. T., Frick, A., Boraxbekk, C.-J., Marquand, A. F., Williams, S. C. R., Carlbring, P., Andersson, G., & Furmark, T. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.22 · Cited by 154
Lueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., Richter, J., Hamm, A., Wittchen, H.-U., & Domschke, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.005 · Cited by 133
Bae, H., Kim, D., & Park, Y. C. (2016) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2015.1037039 · Cited by 104
Metadata
- Authors
- Shin, L. M., Davis, F., VanElzakker, M. B., Dahlgren, M. K., & Dubois, S. J.
- Venue
- Biology of Mood & Anxiety Disorders
- Published
- 2013
- Volume
- 3
- Issue
- 1
- Pages
- 15
- ISSN
- 2045-5380 (ISSN-L)
- OpenAlex
- W2101488453
- Cited by
- 43
- References
- 48
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.